Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Tandem hematopoietic stem cell transplant considerations in families with multiple siblings affected by DOCK8 deficiency

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: The Patient and Parent Experience Following Tandem HSCT for DOCK8 Deficiency.

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Aydin SE, Kilic SS, Aytekin C, Kumar A, Porras O, Kainulainen L, et al. DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients. J Clin Immunol. 2015;35:189–98.

    Article  CAS  PubMed  Google Scholar 

  2. Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med. 2009;361:2046–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Aydin SE, Freeman AF, Al-Herz W, Al-Mousa HA, Arnaout RK, Aydin RC, et al. Hematopoietic stem cell transplantation as treatment for patients with DOCK8 deficiency. J Allergy Clin Immunol Pr. 2019;7:848–55.

    Article  Google Scholar 

  4. Shah NN, Freeman AF, Su H, Cole K, Parta M, Moutsopoulos NM, et al. Haploidentical related donor hematopoietic stem cell transplantation for dedicator-of-cytokinesis 8 deficiency using post-transplantation cyclophosphamide. Biol Blood Marrow Transpl. 2017;23:980–90.

    Article  CAS  Google Scholar 

  5. Dietz AC, Duncan CN, Alter BP, Bresters D, Cowan MJ, Notarangelo L, et al. The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: defining the unique late effects of children undergoing hematopoietic cell transplantation for immune deficiencies, inherited marrow failure disorders, and hemoglobinopathies. Biol Blood Marrow Transpl. 2017;23:24–9.

    Article  Google Scholar 

  6. Pulsipher MA, Skinner R, McDonald GB, Hingorani S, Armenian SH, Cooke KR, et al. National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-specific long-term follow-up guidelines. Biol Blood Marrow Transpl. 2012;18:334–47.

    Article  Google Scholar 

  7. American Academy of Pediatrics. Committee on B. Children as hematopoietic stem cell donors. Pediatrics. 2010;125:392–404.

    Article  Google Scholar 

  8. Bitan M, van Walraven SM, Worel N, Ball LM, Styczynski J, Torrabadella M, et al. Determination of eligibility in related pediatric hematopoietic cell donors: ethical and clinical considerations. recommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation Association. Biol Blood Marrow Transpl. 2016;22:96–103.

    Article  Google Scholar 

  9. Cuellar-Rodriguez J, Freeman AF, Grossman J, Su H, Parta M, Murdock H, et al. Matched related and unrelated donor hematopoietic stem cell transplantation for DOCK8 deficiency. Biol Blood Marrow Transpl. 2015;21:1037–45.

    Article  Google Scholar 

  10. Engelhardt KR, McGhee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol. 2009;124:1289–302. e4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank the patients and their families for participating in this research study at the NCI. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. Figure created with BioRender.com

Funding

This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases and National Cancer Institute, National Institutes of Health (NNS is funded by the Intramural Research Program, Center of Cancer Research, National Cancer Institute, National Institutes of Health (ZIA BC 011823)). This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E.

Author information

Authors and Affiliations

Authors

Contributions

SS, KC, SZB, LW, and NNS designed the study and contributed to the first version of the manuscript. SS and LW developed and conducted parent interviews. SS and SB conducted thematic analysis. AFF, DA, HCS, BY, DH, LW, and NNS, provided patient care. DSW contributed to select sections of the manuscript. JSW, and S-YP, contributed expert insight. BY, and ME provided clinical trial support. No non-author wrote the first draft or any part of the paper. All authors contributed to the review of the final manuscript and have agreed to be co-authors.

Corresponding authors

Correspondence to Sara Silbert or Lori Wiener.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Silbert, S., Cole, K., Bedoya, S.Z. et al. Tandem hematopoietic stem cell transplant considerations in families with multiple siblings affected by DOCK8 deficiency. Bone Marrow Transplant 57, 1721–1723 (2022). https://doi.org/10.1038/s41409-022-01778-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41409-022-01778-4

Search

Quick links